Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2015 1
2016 1
2018 1
2019 1
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Integration of drug safety monitoring in tuberculosis treatment programmes: country experiences.
Tiemersma E, van den Hof S, Dravniece G, Wares F, Molla Y, Permata Y, Lukitosari E, Quelapio M, Aung ST, Aung KM, Thuy HT, Hoa VD, Sulaimanova M, Sagyndikova S, Makhmudova M, Soliev A, Kimerling M. Tiemersma E, et al. Among authors: dravniece g. Eur Respir Rev. 2019 Oct 11;28(153):180115. doi: 10.1183/16000617.0115-2018. Print 2019 Sep 30. Eur Respir Rev. 2019. PMID: 31604816 Free PMC article. Review.
Introducing bedaquiline: experiences from the Challenge TB Project.
Edwards CG, Wares DF, Dravniece G, Gebhard A, Tiemersma E, van der Grinten E, Gidado M, van Weezenbeek K. Edwards CG, et al. Among authors: dravniece g. Int J Tuberc Lung Dis. 2020 Oct 1;24(10):1046-1053. doi: 10.5588/ijtld.19.0790. Int J Tuberc Lung Dis. 2020. PMID: 33126937
Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis.
Abidi S, Achar J, Assao Neino MM, Bang D, Benedetti A, Brode S, Campbell JR, Casas EC, Conradie F, Dravniece G, du Cros P, Falzon D, Jaramillo E, Kuaban C, Lan Z, Lange C, Li PZ, Makhmudova M, Maug AKJ, Menzies D, Migliori GB, Miller A, Myrzaliev B, Ndjeka N, Noeske J, Parpieva N, Piubello A, Schwoebel V, Sikhondze W, Singla R, Souleymane MB, Trébucq A, Van Deun A, Viney K, Weyer K, Zhang BJ, Ahmad Khan F. Abidi S, et al. Among authors: dravniece g. Eur Respir J. 2020 Mar 20;55(3):1901467. doi: 10.1183/13993003.01467-2019. Print 2020 Mar. Eur Respir J. 2020. PMID: 31862767 Free article.
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients.
van de Berg SEJ, Pelzer PT, van der Land AJ, Abdrakhmanova E, Ozi AM, Arias M, Cook-Scalise S, Dravniece G, Gebhard A, Juneja S, Handayani R, Kappel D, Kimerling M, Koppelaar I, Malhotra S, Myrzaliev B, Nsa B, Sugiharto J, Engel N, Mulder C, van den Hof S. van de Berg SEJ, et al. Among authors: dravniece g. BMC Public Health. 2021 Jul 16;21(1):1404. doi: 10.1186/s12889-021-11427-y. BMC Public Health. 2021. PMID: 34271884 Free PMC article.
QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessment.
Monedero-Recuero I, Hernando-Marrupe L, Sánchez-Montalvá A, Cox V, Tommasi M, Furin J, Chiang CY, Quelapio M, Koura KG, Trébucq A, Padanilam X, Dravniece G, Piubello A. Monedero-Recuero I, et al. Among authors: dravniece g. Int J Tuberc Lung Dis. 2018 Oct 26. doi: 10.5588/ijtld.18.0423. Online ahead of print. Int J Tuberc Lung Dis. 2018. PMID: 30366516